Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment
Pharmaceutics · 04.12.2023 · 15 (12) · 2729
DOI: 10.3390/pharmaceutics15122729 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 04.12.2023. Verfasst von Chenyu Zhao und 12 weiteren Autor:innen. Beteiligte Einrichtung: China Medical University-The Queen's University Belfast Joint College, China Medical University, Shenyang 110122, China. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Innovation and Entrepreneurship Training Program for College Students of China Medical University, National Natural Science Foundation of China, Liaoning Provincial Science and Technology Plan Project.
Abstract (Originalsprache)
Cancer is a serious disease with an abnormal proliferation of organ tissues; it is characterized by malignant infiltration and growth that affects human life. Traditional cancer therapies such as resection, radiotherapy and chemotherapy have a low cure rate and often cause irreversible damage to the body. In recent years, since the traditional treatment of cancer is still very far from perfect, researchers have begun to focus on non-invasive near-infrared (NIR)-responsive natural macromolecular hydrogel assembly drugs (NIR-NMHADs). Due to their unique biocompatibility and extremely high drug encapsulation, coupling with the spatiotemporal controllability of NIR, synergistic photothermal therapy (PTT), photothermal therapy (PDT), chemotherapy (CT) and immunotherapy (IT) has created excellent effects and good prospects for cancer treatment. In addition, some emerging bioengineering technologies can also improve the effectiveness of drug delivery systems. This review will discuss the properties of NIR light, the NIR-functional hydrogels commonly used in current research, the cancer therapy corresponding to the materials encapsulated in them and the bioengineering technology that can assist drug delivery systems. The review provides a constructive reference for the optimization of NIR-NMHAD experimental ideas and its application to human body.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- China Medical University-The Queen's University Belfast Joint College, China Medical University, Shenyang 110122, China.
- Department of Chemistry, School of Forensic Medicine, China Medical University, Shenyang 110122, China.
- Liaoning Province Key Laboratory of Forensic Bio-Evidence Sciences, Shenyang 110122, China.
- Center of Forensic Investigation, China Medical University, Shenyang 110122, China.
- Department of Biophysics, School of Intelligent Medicine, China Medical University, Shenyang 110122, China.
- School of Pharmacy, Queen's University Belfast, Belfast BT7 1NN, UK.
ORCID-Profile: Chenyu Zhao, Boyue Pan, Tianlin Wang, Huazhe Yang, Yang Wang
Förderung
- Innovation and Entrepreneurship Training Program for College Students of China Medical University
- National Natural Science Foundation of China
- Liaoning Provincial Science and Technology Plan Project
- Scientific Research Funding Project of Liaoning Provincial Department of Education
Zitieren
APA
Zhao, C., Pan, B., Wang, T., Yang, H., Vance, D., Li, X., Zhao, H., Hu, X., Yang, T., Chen, Z., Hao, L., Liu, T., & Wang, Y. (2023). Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment. Pharmaceutics, 15(12), 2729. https://doi.org/10.3390/pharmaceutics15122729
Vancouver
Zhao C, Pan B, Wang T, Yang H, Vance D, Li X, et al. Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment. Pharmaceutics. 2023;15(12):2729. doi:10.3390/pharmaceutics15122729
BibTeX
@article{Zhao2023,
author = {Zhao, Chenyu and Pan, Boyue and Wang, Tianlin and Yang, Huazhe and Vance, David and Li, Xiaojia and Zhao, Haiyang and Hu, Xinru and Yang, Tianchang and Chen, Zihao and Hao, Liang and Liu, Ting and Wang, Yang},
title = {Advances in NIR-Responsive Natural Macromolecular Hydrogel Assembly Drugs for Cancer Treatment},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {12},
pages = {2729},
doi = {10.3390/pharmaceutics15122729}
}
EUVIMED